ORIGINAL STUDIES |
|
Viktorova I.A., Ivanova D.S., Nechaeva G.I., Potapov V.V., Tikhonova O.V., Goloshubina V.V., Adyrbaev A.M.
Rehabilitation of patients with connective tissue dysplasia in outpatient practice
|
8-17 |
|
Druk I.V., Nechaeva G.I., Ambartsumyan D.B., Kotova L.I., Drokina O.V., Bilevich O.A.
Incidence degree of congenital urinary system abnormalities and conjunctive tissue dysplasia among terminal chronic renal failure patients
|
18-26 |
|
Chernova A.A., Nikulina S.Yu., Matyushin G.V., Lebedeva I.I.
Signs of connective tissue dysplasia and the gene for endothelial nitric synthase type 3 (NOS3) in case of Wolff–Parkinson–White syndrome
|
27-34 |
|
Yalaev B.I., Tyurin A.V., Nurlygayanov R.Z., Khusainova R.I.
Role of microRNA in multifactorial connective tissue pathology
|
35-39 |
|
Vershinina M.V., Nechaeva G.I., Gudilin V.A.
Relative cardiovascular risk in young patients with connective tissue dysplasia
|
40-44 |
|
Yagoda A.V., Airapetian L.A.
Polymorphisms of thrombophilia genes with some visceral signs of connective tissue dysplasia
|
46-51 |
|
Druk I.V., Nechaeva G.I., Rezinovskaya T.L.
Deficiency of body mass in a group of young-age patients with connective tissue dysplasia
|
52-58 |
|
Nesterenko Z.V.
From the phenotype of connective tissue dysplasia to the phenotype of bronchial asthma in children
|
59-63 |
|
Dakuko A.N., Krivtsova L.A., Nalobina A.N., Ivaschenko O.N., Plekhanova M.A.
Influence of connective tissue dysplasia at the formation of adaptive and functional capabilities in children engaging precise technical sports activities
|
64-70 |
|
Rudoy A.S., Uryvaev A.M.
Pathogenesis of pre-malignant gastric lesions in patients with Marfan syndrome
|
71-81 |
|
Akhiyarova K.E., Sadretdinova L.D., Akhmetova А.М., Gantseva Kh.Kh., Khusainova R.I., Tyurin A.V.
Study of bone mineral density in young people with pain syndrome of different localization
|
82-87 |
|
Smolnova T.Yu., Trofimov D.Yu., Chuprynin V.D., Nechaeva G.I.
To the point about etiopathogenetic causes of Marfan-like phenotype (marfanoid appearance) formation
|
88-92 |
|
Vavilova V.P., Vavilov A.M., Perevochikova N.K., Tsarkova S.A., Pivovar O.I., Klimova I.I.
Experience of preventing new coronavirus infection (COVID-19) among healthcare workers
|
93-102 |
|
Izmozherova N.V., Popov A.A., Gavrilova E.I., Kuryndina A.A., Tagiltseva N.V. Shambatov M.A.
Community-acquired pneumonia course peculiarities in comorbid patients hospitalized during the epidemic of respiratory viral infections
|
103-112 |
REVIEWS |
|
Semenova E.V., Nechaeva G.I., Loginova E.N., Semenkin A.A.
Hereditary connective tissue disorders: a thematic bibliographic review of foreign publications
|
114-122 |
|
Ivanova D.S., Viktorova I.A., Kochimov R.S, Adyrbayev A.M.
Diagnostics and tactics of management of patients with signs of connective tissue dysplasia, headache and disorder of sensitivity. Literature review
|
124-130 |
|
Gladkikh N.N., Yagoda A.V.
Dysplastic phenotype of patients with primary mitral valve prolapse. Literature review
|
131-138 |
|
Shishkova V.N., Martynov A.I.
Modern opportunities of therapy for metabolic cardiomyopathy and heart failure
|
139-149 |
GUIDELINES FOR PRACTITIONERS |
|
Smolnova T.Yu., Trofimov D.Yu., Chuprynin V.D., Chursin V.V.
Mutation in the ADAMTSL4 gene in a patient with a Marfan-like phenotype (Marfanoid appearance) without Ectopia lentis with uterine scar failure after cesarean section
|
150-155 |
|
Smolnova T.Yu., Trofimov D.Yu., Chuprynin V.D.
The role of tenascin gene (TNXB) mutation in Ellers-like phenotype formation in patients with genital prolapse
|
156-162 |
|
Tarasova L.V., Dimitrieva O.V., Busalaeva E.I., Vasilieva N.P.
Pulmonary embolism as early manifestation of malignant neoplasm of the pancreas
|
163-170 |
LECTURE |
|
Pereverzev A.P., Ostroumova O.D.
Drug-induced gastrointestinal damage: Part I – types and pathophysiological mechanisms of lesion)
|
171-183 |
|
Bozhko E.P., Wagenleitner N.V.
Specific features of the press service of medical University
|
184-189 |
ACTUAL ISSUES OF PHARMACOTHERAPY |
|
Dydykina I.S., kovalenko P.S., nurbayeva K.S., arutyunova E.V., kozhevnikova P.O.
Pathogenetic justification of the use of the vitamin-mineral complex calciren for the prevention and complex correction of osteoporosis
|
190-201 |
|
Eliseeva l.N., Kartashova S.V.
Mexidol® and mexidol® forte 250 in consecutive therapy of cognitive disorders in comorbid patients with joint pathology on the background of arterial hypertension and ischemic heart disease
|
202-211 |
|
Pilat T.L., Khanferian R.A.
Specialized dietary preventive and therapeutic products as a means of increasing the efficiency of gastrointestinal diseases pharmacotherapy
|
212-218 |
Русский
